JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Arlington Asset Investment Corp. Announces Pricing of 8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock Offering
-
Bandwidth, Inc. (BAND) to Offer 2.25M Sharesa
-
Bandwidth Announces Commencement of Public Offering of Common Stock
-
Shotspotter (SSTI) to Offer Common Stock
-
ShotSpotter Announces Public Offering of Common Stock
-
American Mortgage Consultants, Inc. Acquires String Real Estate Information Services, LLC
-
Arbor Realty Trust (ABR) PT Raised to $14 at JMP Securities
-
Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility
-
Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility
-
JMP Securities Upgrades Redwood Trust (RWT) to Market Outperform
-
Cushman & Wakefield (CWK) PT Raised to $21 at JMP Securities
-
Tesla (TSLA) Dealership Savings Makes $35K Model 3 Feasible - JMP
-
Workday (WDAY) PT Raised to $220 at JMP Securities
-
TPI Composites (TPIC) PT Raised to $41 at JMP Securities
-
Starwood Property Trust (STWD) PT Raised to $24 at JMP Securities
-
Nutanix (NTNX) PT Lowered to $52 at JMP Securities
-
Horizon Pharma (HZNP) PT Raised to $38 at JMP Securities
-
JMP Securities Downgrades iStar Financial (STAR) to Market Perform
-
Itron (ITRI) PT Lowered to $72 at JMP Securities
-
Encore Capital Inc. (ECPG) PT Raised to $42 at JMP Securities
-
Form X-17A-5 JMP SECURITIES LLC For: Dec 31
-
Veeva Systems (VEEV) PT Raised to $122 at JMP Securities
-
TRI Pointe Homes (TPH) PT Raised to $15 at JMP Securities
-
LGI Homes (LGIH) PT Raised to $68 at JMP Securities
-
Engagio Launches First Engagement-Based Attribution Capability for Measuring Both Marketing and Sales Impact
-
Aerie Pharma (AERI) PT Lowered to $75 at JMP Securities
-
Hercules Technology Growth Capital (HTGC) PT Raised to $15.50 at JMP Securities
-
Questback to Present at the JMP Securities 2019 Technology Conference
-
Zillow Group Co-Founder and CEO Rich Barton to Keynote JMP Securities Technology Conference
-
Zillow Group Co-Founder and CEO Rich Barton to Keynote JMP Securities Technology Conference
-
JMP Securities Starts New Fortress Energy (NFE) at Market Outperform
-
TrueCar to Participate in Upcoming Conferences
-
RealPage to Participate in Upcoming Investor Conferences
-
EverQuote to Present at the JMP Securities Technology Conference
-
EverQuote to Present at the JMP Securities Technology Conference
-
ShotSpotter to Present at the JMP Securities Technology Conference on February 26, 2019
-
APX Group Holdings, Inc. to Attend Upcoming Conferences
-
Stifel Announces Pricing of $150 Million of Non-Cumulative Perpetual Preferred Stock
-
Elevate Credit, Inc. to Participate in the JMP Securities Technology Conference
-
CORRECTING and REPLACING - Domo Executives to Participate in Upcoming Investor Events
-
CORRECTING and REPLACING - Domo Executives to Participate in Upcoming Investor Events
-
GoDaddy Inc (GDDY) PT Raised to $93 at JMP Securities
-
Institute for Blockchain Innovation (IBI) Adds Security Token Leaders from JMP Securities, Hyperion, Huobi (MENA), Invector Labs and others
-
Demandbase to Release Account-Based Marketing Book at 6th Annual ABM Innovation Summit
-
PLx Pharma Inc. Announces Completion of $15 Million Convertible Preferred Stock Financing
-
JMP Securities Upgrades OrthoPediatrics Corp. (KIDS) to Market Outperform
-
UPDATE: Ovid Therapeutics (OVID) Prices 12.5M Share Common Offering at $2/Sh; Announces Pricing of 2500 Preferred Share Offering
-
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
-
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
-
BlackLine Announces Participation in Upcoming Investor Conferences

